Ian L. Brown (Duke University)
Dr. Ian Lee Brown is the Vice President and Chief Employee Experience Officer at Duke University Health System (DUHS), where he leads initiatives focused on employee well-being and workplace safety. His work fosters a culture where employees can be their authentic selves while delivering exceptional care. Before DUHS, Brown held senior roles in healthcare, senior living, and education, managing over 1,200 employees and $200 million budgets. He serves on boards supporting higher education, healthcare, and affordable housing. Brown earned his degrees from Brooklyn College, Lake Forest College, and Johns Hopkins University, where he also completed a Graduate Certificate in Senior Housing and Healthcare and attended the Bloomberg School of Public Health’s Mid-Atlantic Health Leadership Institute. His leadership focuses on creating inclusive workplaces that support employees and enhance the patient experience across diverse communities.
Roland J. Thorpe (Johns Hopkins University)
Roland J. Thorpe, Jr., PhD, MS, is a Professor in the Department of Health, Behavior, and Society, Founding Director of the Program of Men’s Health Research in the Hopkins Center for Health Disparities Solutions (HCHDS), Deputy Director of HCHDS, and Co-Director of the Johns Hopkins Alzheimer’s Disease Resource Center for Minority Aging Research at Johns Hopkins Bloomberg School of Public Health. He was recently appointed as the inaugural Associate Vice Provost of Faculty Diversity. He holds joint appointments in the Division of Geriatric Medicine and Gerontology in the Department of Medicine, and the Department of Neurology at the Johns Hopkins School of Medicine, and the Department of Sociology at the Krieger School of Arts and Sciences at Johns Hopkins University. Dr. Thorpe is a social epidemiologist whose research focuses on the association of how social and structural determinants of health impact health and functional outcomes among men across the adult life course. He is particularly interested in two areas: disentangling race and SES inequalities across the life course, and understanding how structural inequalities impact biology to affect health and health behaviors. Dr. Thorpe serves as multiple principal investigator (MPI) on several NIA funded grants and is a MPI of the Artificial Intelligence/ Machine Learning consortium to Advance Health Equity and Researcher Diversity (AIM-AHEAD) with a focus on increasing the participation and engagement of the researchers and communities that are currently underrepresented in AI/ML modeling and applications through mutually beneficial partnerships. He participates in several training programs designed to develop under-represented minorities at many career stages. He is a past recipient of the Johns Hopkins School of Public Health Advising, Mentoring, and Teaching Recognition Award, the inaugural annual 2018 NHLBI OHD PRIDE Roland J. Thorpe, Jr. mentoring award, recipient of the 2020 Minority Issues in Gerontology Outstanding Mentorship Award and the 2020 JHBSPH Dean’s Award of Distinction in Faculty Mentoring. Dr. Thorpe is also the Editor in Chief of Ethnicity & Disease, Associate Editor for Innovation in Aging, Journal of Gerontology: Medical Sciences, and American Journal of Men’s Health. Dr. Thorpe earned a bachelor’s in theoretical mathematics from Florida A&M University, a master’s in statistics, a Ph.D. in clinical epidemiology with a graduate minor in gerontology from Purdue University, and received postdoctoral training in health disparities and gerontology from the Division of Geriatric Medicine and Gerontology at the Johns Hopkins School of Medicine.
Goldie Smith Byrd (Wake Forest School of Medicine)
Dr. Goldie Smith Byrd is the Director of the Maya Angelou Center for Health Equity and a Professor of Social Sciences and Health Policy at Wake Forest School of Medicine. She is a nationally renowned researcher focusing on health equity, the genetics of Alzheimer’s disease in African Americans, and the inclusion of minorities in research and clinical trials. Dr. Byrd began exploring these research areas in 2002 while on faculty at Duke University Medical Center. She serves on the executive board of the North Carolina Institute of Medicine and co-led the task force that created North Carolina’s strategic plan for addressing Alzheimer’s and dementia, leading to the establishment of the North Carolina Registry for Brain Health. Dr. Byrd has received numerous local, state, and national awards, including the prestigious Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring at a White House ceremony. She has served on multiple study sections, advisory boards, and panels for the National Institutes of Health, the National Science Foundation, the National Academies of Sciences, the Alzheimer’s Association, and pharmaceutical companies including Merck, Biogen, and Takeda Pharmaceutical.
Felix Kabo (University of Michigan, CannonDesign)
Dr. Felix Kabo is a Research Fellow at the University of Michigan’s Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies and serves as the Director of Research at CannonDesign. He specializes in sociospatial network science, focusing on how spatial and social contexts influence various societal outcomes, including collaboration, innovation, entrepreneurship, aging, and health disparities. Dr. Kabo has held research faculty positions at the University of Michigan’s Institute for Social Research and is affiliated with the Michigan Institute for Clinical and Health Research and the Institute for Healthcare Policy and Innovation. His work has been widely published in leading academic journals and presented at national and international conferences. In his role at CannonDesign, he leads firm-wide research initiatives, systematically assessing design solutions using performance indicators aligned with Living-Centered Design.
Kacie Deters (University of California, Los Angeles)
Dr. Kacie D. Deters is an Assistant Professor in the Department of Integrative Biology and Physiology at the University of California, Los Angeles (UCLA). She earned her B.S. in Biology from the University of Alabama at Birmingham, followed by an M.S. in Biology from California State University, Dominguez Hills in 2012. In 2017, she completed her Ph.D. in Medical Neuroscience at the Indiana University School of Medicine, focusing on the genetic and imaging characteristics of tauopathies, including Alzheimer’s disease. Dr. Deters pursued postdoctoral research at Stanford University, where she investigated ethnic and racial disparities in Alzheimer’s disease biomarkers, and at the University of California, San Diego, where she examined racial biases in neuropsychological assessments. At UCLA, her lab focuses on understanding ethnic and racial disparities in predictors of cognitive decline and Alzheimer’s disease among older adults, primarily within the Black community. Her research employs a multidisciplinary approach, incorporating genetics, neuroimaging, neuropsychological assessments, and social/environmental factors. Dr. Deters is also the Program Lead for the Black in Neuro Seminar Series. Beyond her academic pursuits, she enjoys cooking, visiting Disneyland, and watching movies.
Ryan Powell (University of Wisconsin–Madison)
Dr. W. Ryan Powell is an Assistant Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin School of Medicine and Public Health. As the Associate Director for Social Science at the Center for Health Disparities Research (CHDR), he leads scientific initiatives and fosters collaborative research to understand the social determinants of health and related disparities. Dr. Powell oversees research development for the 22-site NIH Neighborhoods Study, the largest study of its kind evaluating how the social exposome impacts the biological processes underlying Alzheimer’s disease and related dementias. He also leads NIA-funded research studying the impact of the occupational exposome on Alzheimer’s disease risk. Dr. Powell earned his PhD in Health Services Research from Boston University School of Public Health and an MA in Experimental Psychology from Wake Forest University. His research focuses on how social and environmental conditions over a lifetime affect brain health, including the role of the military exposome in influencing Alzheimer’s disease and related dementia risks. He is dedicated to promoting health equity by facilitating interdisciplinary collaborative science that leads to new research discoveries and practical ways to address the causes of health disparities.
Jan Krumsiek (Weill Cornell Medicine)
Dr. Jan Krumsiek is an Associate Professor at Weill Cornell Medicine, affiliated with the Department of Physiology and Biophysics and the Englander Institute for Precision Medicine. He specializes in developing computational methods for analyzing metabolomics and multi-omics data, employing pathway-based approaches, computational simulations, and machine learning techniques. A key focus of his research is the inference of metabolic networks from data, providing condition-specific, unbiased in vivo insights into metabolism. Dr. Krumsiek has extensively published on the etiology and risk prediction of diabetes and obesity and is currently expanding his research into cancer, investigating metabolic associations of drug treatments and clinical parameters across various cancer types. He earned his Ph.D. in 2012 and M.Sc. in 2009 from the Technical University of Munich, Germany. Before his current role, he served as a Visiting Fellow in Medicine at Weill Cornell Medical College from 2013 to 2018.
Matthias Arnold (Helmholtz University and Duke University)
Dr. Arnold is a Research Team Leader for Computational Neurobiology at Helmholtz Munich and an Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences at Duke University. He received his PhD in computational biology from the Technical University Munich. Dr. Arnold’s research focuses on metabolic underpinnings of Alzheimer’s disease (AD) pathogenesis that he interfaces with genomics, transcriptomics, proteomics, and gut microbiome data for fine mapping of disease-relevant pathways. Primary applications of the derived publicly available network-based multi-omics Atlas for AD are the identification of novel biomarkers, prioritization of potential therapeutic targets, and development of computational drug repositioning approaches for AD.
Solmaz Amiri (Washington State University)
Dr. Solmaz Amiri is an Assistant Research Professor at Washington State University’s Institute for Research and Education to Advance Community Health (IREACH). She holds a Doctor of Design from WSU’s School of Design and Construction and a Master of Science in Architecture. Dr. Amiri specializes in Geographic Information Systems (GIS) and geospatial statistics, applying these methodologies to a broad spectrum of research areas, including public health, crime, and transportation. Her expertise encompasses gathering and processing geospatial data, modeling large datasets, and data visualization using platforms like ArcGIS. Her dissertation, funded by the National Institute of Justice, involved developing a geospatial tool to forecast residential burglaries. Throughout her over 12-year tenure at WSU Spokane, Dr. Amiri has been Principal or Co-Investigator on multiple grants, employing GIS and statistical techniques to examine individual, social, and spatial factors associated with various health outcomes, such as substance use, mental health, cancers, Alzheimer’s disease, and respiratory diseases. She has also developed and taught quantitative research methods and statistics courses to undergraduate and graduate students at WSU. Dr. Amiri is dedicated to advancing health equity and understanding the complex interplay between environment and health.
Konstantin Arbeev (Duke University)
Dr. Konstantin G. Arbeev is an Associate Research Professor in the Social Science Research Institute at Duke University. He earned his Ph.D. in Mathematics and Physics from St. Petersburg State University in 1999. Dr. Arbeev’s research focuses on biodemography and aging, employing mathematical modeling, biostatistics, and genetic epidemiology to investigate factors influencing longevity and age-related health outcomes. He has contributed to studies on genetic and environmental determinants of aging, the role of biomarkers in healthspan, and the development of statistical methods for analyzing complex longitudinal data. Dr. Arbeev has published extensively in peer-reviewed journals and collaborates with interdisciplinary teams to advance the understanding of aging processes. His work aims to inform interventions that promote healthy aging and longevity.
Igor Akushevich (Duke University, Social Science Research Institute)
Igor Akushevich, PhD, is a Research Professor at the Biodemography Research Unit of the Social Science Research Institute. His expertise includes a biodemography, epidemiology, causal methods, and advanced statistical modeling of health effects with specific focus on health disparities, cognitive disorders, and multimorbidity in older US adults. His current research is focused on quantitative evaluation of the mechanisms underlying disease-specific time trends and racial and geographic disparities in Alzheimer’s disease and related dementia, impacts of clinic-related factors and social determinants to these trends, as well as on leveraging existing and developing new approaches to large population-based data analysis.
Daniel Powers (University of Texas at Austin)
Dr. Daniel A. Powers is a Professor in the Department of Sociology at the University of Texas at Austin, affiliated with the Population Research Center and the Division of Statistics and Scientific Computation. His research focuses on health disparities, particularly the Hispanic infant mortality paradox and race ethnic comparisons of infant mortality trends. His current work examines how the Mexican origin infant survival advantage declines with increasing maternal age and investigates racial ethnic differences in birth outcomes for women over 30. He also analyzes black white disparities in infant mortality over 20 years using an age period cohort perspective, finding that period effects have the strongest influence on mortality change. Methodologically, he specializes in survival modeling, regression decomposition, and the intrinsic estimator. A statistical computing programmer, he has contributed Stata and R algorithms for demographic analysis. He was graduate advisor in the MS in Statistics program from 2006 to 2012.
Soojin Park (University of California, Riverside)
Dr. Soojin Park is an Associate Professor of Quantitative Methods in the School of Education at the University of California, Riverside. Her research focuses on developing and validating quantitative methods for causal inference, which she applies to investigate factors contributing to racial and gender disparities in educational and health outcomes. In 2023, Dr. Park received a National Science Foundation grant to develop methods identifying risk factors leading to social disparities, including those related to race, ethnicity, gender, and sexual orientation. She has published works such as “Causal Decomposition Analysis with Time-Varying Mediators” and “Examining Cumulative Inequality in the Association Between Childhood Socioeconomic Status and Body Mass Index from Midlife to Old Age.” Dr. Park teaches courses in experimental design and quantitative research methods at both undergraduate and graduate levels. She earned her Ph.D. in Quantitative Methods from the University of Wisconsin-Madison./span>
Feixiong Cheng (Cleveland Clinic)
Dr. Feixiong Cheng is the Director of the Cleveland Clinic Genome Center and a Principal Investigator in the Genomic Medicine Institute at Cleveland Clinic. His research focuses on utilizing genomic science and systems biology to predict drug targets and identify mechanisms for Alzheimer’s disease. Dr. Cheng’s expertise includes analyzing, visualizing, and mining data from real-world sources, such as electronic health records and healthcare claims, as well as experimental data profiling the molecular state of human cells and tissues through interactomics, transcriptomics, genomics, proteomics, and metabolomics. His work aims to advance personalized drug discovery and precise patient care. In 2023, Dr. Cheng was appointed as the inaugural director of the Cleveland Clinic Genome Center, where he leads efforts to advance genetic and genomic sciences and their applications to novel biomedical discoveries. He has published extensively in peer-reviewed journals and collaborates with interdisciplinary teams to advance the understanding of complex diseases.
Eleanor Hayes-Larson (University of Southern California)
Dr. Dr. Eleanor Hayes-Larson is an Assistant Professor of Gerontology at the University of Southern California’s Leonard Davis School of Gerontology. She holds a PhD in Epidemiology from Columbia University and an MPH from Yale University. Her research integrates social, psychiatric, and neuroepidemiology with advanced statistical methods to understand drivers of cognitive decline and dementia disparities. Focusing on psychosocial determinants across the life course, she emphasizes studying diverse populations, including groups historically underrepresented in research. A significant aspect of her work examines the impact of traumatic stress on cognitive decline, dementia, and neuroimaging biomarkers. Additionally, Dr. Hayes-Larson focuses on improving statistical tools for causal inference and generalizability in cognitive aging research.
George Demiris (University of Pennsylvania)
Dr. George Demiris is the Mary Alice Bennett University Professor at the University of Pennsylvania, holding joint appointments in the School of Nursing and the Perelman School of Medicine. As Associate Dean for Research and Innovation in the School of Nursing, he explores innovative ways to utilize technology to support patients and their families in various settings, including home and hospice care. His research focuses on designing and evaluating personal health systems that produce patient-generated data, such as “smart home” solutions for aging, aiming to support independence and quality of life for community-dwelling older adults. Dr. Demiris is a member of the National Academy of Medicine and a fellow of the American College of Medical Informatics, the Gerontological Society of America, and the International Academy of Health Sciences Informatics. He directs the Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging and co-directs the Penn Community Collaboratory for Co-Creation. His work has been consistently funded by the National Institutes of Health and the National Science Foundation.
Xi Chen (Yale University)
Dr. Xi Chen is an Associate Professor at Yale University, holding appointments in Public Health (Health Policy), Global Health, and Economics. His research focuses on health and development economics, particularly the economics of aging, health systems, and the impact of environmental factors on health. Dr. Chen investigates how social interactions influence health behaviors and outcomes, as well as the socioeconomic drivers of health disparities. He is a faculty fellow at the Yale Institution for Social and Policy Studies, the Yale Alzheimer’s Disease Research Center, and the Yale Center for Climate Change and Health. Dr. Chen serves as an editor for the Journal of Population Economics and has consulted for organizations such as the World Bank and the United Nations. He earned his Ph.D. in Applied Economics from Cornell University.
Laura Wang (Duke University)
Laura Wang is a senior at Duke University, majoring in Neuroscience with a focus on global health. She has conducted research on the therapeutic effects of immune checkpoint blockade, radiation therapy, and other immunomodulatory agents at the Kirsch Lab. Laura participated in the Bass Connections project “Revolutionizing Mental Healthcare With Data,” where she engaged in discussions on public policy issues, collaborated with companies utilizing real-world mental health data, and developed policy recommendations through researching ethical frameworks. She also took part in the Student Research Training Program, contributing to community-based global health projects. Laura is committed to integrating neuroscience and global health to address disparities in mental health care.
Sarah Forrester (University of Massachusetts)
Dr. Sarah N. Forrester is an Associate Professor in the Division of Epidemiology within the Department of Population and Quantitative Health Sciences at the University of Massachusetts Medical School. Her research focuses on health disparities, health equity, and biological determinants of health, with an emphasis on how social and environmental factors contribute to disparities in chronic disease outcomes. She has published in peer-reviewed journals, including Research on Aging, contributing to the understanding of aging, mental health, and population health inequities. Dr. Forrester is also a member of the Collaborative in Health Equity at UMass Chan Medical School, where she engages in community-based participatory research addressing social determinants of health. She integrates epidemiology, biostatistics, and public health methodologies to identify intervention strategies for reducing health disparities. She is an active mentor and educator, teaching courses in epidemiology and public health research. Dr. Forrester also engages with the public through social media, sharing insights related to public health and health equity.
Julia Kravchenko (Duke University School of Medicine)
Julia Kravchenko (a.k.a. Yuliya Krauchanka) is an Assistant Professor of Surgery in the Division of Surgical Sciences at Duke University School of Medicine. She earned her M.D. from Belarusian State Medical University in 1992 and her Ph.D. from the Belarusian Medical Academy of Postgraduate Education in 1999. Dr. Krauchanka’s research focuses on surgical innovations, patient outcomes, and the integration of advanced medical technologies to improve surgical care. In addition to her role in surgery, she is also an Assistant Professor in Population Health Sciences at Duke, where she applies an interdisciplinary approach to healthcare research. Her work bridges clinical practice and population health, aiming to enhance patient care through data-driven strategies. Dr. Krauchanka is actively involved in mentoring students and training the next generation of surgeons and medical researchers. She has contributed to numerous peer-reviewed publications and collaborates on research projects that seek to optimize surgical techniques and healthcare delivery.
Kristina Dang (University of Southern California)
Dr. Kristina Van Dang is a researcher whose work focuses on the intersection of environmental exposures and cognitive health in aging populations. She earned her Bachelor of Arts degrees in Economics and Molecular and Cell Biology from the University of California, Berkeley, and a Master of Public Health in Epidemiology from Emory University. In 2023, she completed her doctoral studies at the University of California, San Francisco, with a dissertation titled “Role of air pollution and socioeconomic position on cognition over six years in older adults in the United States,” under the guidance of Dr. M. Maria Glymour. Her research examined how air pollution and socioeconomic factors jointly influence cognitive trajectories in older adults, highlighting the complex interplay between environmental and social determinants of health. Dr. Dang has also investigated the combined effects of air pollution and heat exposure on epigenetic aging, contributing to the understanding of how environmental stressors accelerate biological aging processes. Her work aims to inform public health interventions that mitigate environmental risks and promote cognitive resilience in vulnerable populations.
Maggie Calkins (IDEAS Institute)
Dr. Margaret “Maggie” Calkins is a leading expert in designing environments for older adults, particularly those with dementia. She is the President and Board Chair of the IDEAS Institute, which researches how social, organizational, and physical environments impact aging and dementia care. Dr. Calkins has published extensively, including Design for Dementia and Creating Successful Dementia Care Settings, shaping best practices in senior care design. She has secured over $6 million in grant funding from the NIH and other organizations to study environmental impacts on dementia care. A sought-after speaker, she presents internationally on aging and dementia-friendly design. Dr. Calkins is a founding member of SAGE and has served on boards for the Pioneer Network and the American Society on Aging. She is a fellow of the Gerontological Society of America and holds a Ph.D. in Architecture. Her work continues to influence policies and design strategies for improving quality of life in aging populations.
Marianne Chanti-Ketterl (Duke University School of Medicine)
Dr. Marianne Chanti-Ketterl is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine, specializing in the epidemiology of aging. She also serves as a Senior Fellow at Duke’s Center for the Study of Aging and Human Development. As the Associate Core Lead for the Outreach Recruitment and Engagement Core of the Duke-UNC Alzheimer’s Disease Research Center, Dr. Chanti-Ketterl focuses on building trust within the community and engaging historically marginalized populations. Her research examines environmental factors influencing cognitive function, Alzheimer’s disease, and related dementias, with interests in the exposome, pesticide exposure, social determinants of health, traumatic brain injuries, metabolic biomarkers, resilience, and cognitive training. Dr. Chanti-Ketterl earned her Ph.D. in Aging Studies and M.S.P.H. from the University of South Florida, followed by a postdoctoral fellowship at Duke University funded by the National Institutes of Health and the National Institute on Aging. She is bilingual in Spanish and English, enhancing her ability to conduct inclusive research and outreach.
Eric Stallard (Duke University)
Eric Stallard is a Research Professor at Duke University and Co-Director of the Biodemography of Aging Research Unit. His expertise encompasses biomedical demography, with a focus on modeling and forecasting health trends and long-term care needs. Prof. Stallard has contributed significantly to the field through his research on biodemography of aging, particularly in the context of Alzheimer’s disease and related disorders. He is affiliated with the Duke-UNC Alzheimer’s Disease Research Center, where he collaborates on studies examining the genetic underpinnings of neurodegenerative diseases. Throughout his career, Prof. Stallard has published extensively, advancing the understanding of aging processes and informing public health strategies. His work integrates demographic methods with genetic research to explore the complex factors influencing aging and longevity. He has won many awards for his research, including the National Institute on Aging James A. Shannon Director’s Award, the Society of Actuaries’ Edward A. Lew Award for Best Paper in Modeling Research, and the American Statistical Association’s Eric Ziegel Award for Best Book reviewed in Technometrics.
Matthew Baumgart (Alzheimer’s Association)
Matthew Baumgart serves as the Vice President of Health Policy at the Alzheimer’s Association, where he leads initiatives to enhance care and support for individuals affected by Alzheimer’s disease and other dementias. In this role, he has been instrumental in advocating for comprehensive dementia care management models, emphasizing the importance of integrating care coordination, caregiver support, and interdisciplinary healthcare teams to improve patient outcomes and reduce costs. Baumgart has highlighted that dementia is one of the costliest conditions to society, with costs reaching $321 billion in 2022 alone. He has also emphasized the significant emotional, financial, and physical challenges faced by caregivers, noting that twice as many caregivers of those with dementia report substantial difficulties compared to caregivers of people without dementia. His efforts have been pivotal in shaping public health policies and legislation aimed at addressing the complex challenges posed by dementia, including the development of public health road maps in partnership with the Centers for Disease Control and Prevention (CDC). Baumgart’s work underscores the critical need for a multifaceted approach to dementia care that encompasses both medical treatment and comprehensive support services.
Heather Whitson (Duke University Medical Center)
Dr. Whitson’s research is focused on improving care options and resilience for people with multiple chronic conditions. In particular, she has interest and expertise related to how comorbidities and biological aging affect the brain. Dr. Whitson is the Director of the Duke Center for the Study of Aging & Human Development (aka Duke Aging Center). She also co-Directs the Duke University and the University of North Carolina Alzheimer’s Disease Research Center (Duke/UNC ADRC), an NIH ADRC with a bold vision to transform dementia care and research across Eastern North Carolina. The scientific theme of the Duke/UNC ADRC is to understand factors across the lifespan that contribute to the development, progression, or experience of Alzheimer’s disease.
Murali Doraiswamy (Duke University School of Medicine)
Murali Doraiswamy MBBS FRCP is Professor of Psychiatry and Professor in Medicine at Duke University School of Medicine where he is a highly cited physician scientist at the Duke Institute for Brain Sciences. He is also a Senior Fellow at the Duke Center for the Study of Aging and an Affiliate Faculty at the Duke Center for Precision Medicine and Applied Genomics as well as the Duke Microbiome Center. He directs a clinical trials unit that has been involved in the development of many modern diagnostic tests, apps, algorithms, and therapeutics in wide use today. Prof Doraiswamy has been an advisor to leading government agencies, businesses and advocacy groups including the NIH, FDA, and WHO as well as numerous life science companies.
Geoffrey Ginsburg (All of US Research Program)
Dr. Geoffrey Ginsburg is the Chief Medical and Scientific Officer of the All of Us Research Program at the NIH, where he leads the program’s scientific vision and data strategy to advance precision medicine. Prior to this role, he was the founding director of the Center for Applied Genomics & Precision Medicine at Duke University and held professorships in Medicine, Pathology, Biostatistics, Biomedical Engineering, and Nursing. Dr. Ginsburg has co-chaired the National Academies’ Roundtable on Genomic and Precision Health and founded the Global Genomic Medicine Collaborative. He has also held leadership roles at Millennium Pharmaceuticals and Harvard Medical School. His research spans oncology, infectious diseases, cardiovascular disease, and metabolic disorders. Dr. Ginsburg earned his M.D. and Ph.D. in Biophysics from Boston University and completed his medical training at Beth Israel Hospital in Boston. His work continues to shape the future of genomic research and personalized medicine.
Carl V. Hill (Alzheimer’s Association)
Dr. Carl V. Hill, Ph.D., MPH, serves as the Chief Diversity, Equity, and Inclusion Officer for the Alzheimer’s Association. In this role, he leads strategic initiatives to enhance the organization’s outreach across diverse populations, ensuring that all communities have access to resources and support to address Alzheimer’s disease. Dr. Hill is responsible for driving organization-wide efforts to address systemic health inequities in treatment, clinical trials, and research. He spearheaded the Association’s inaugural national conference dedicated to addressing disparities and promoting equity in dementia science. Under his leadership, the Association has established partnerships with over 30 national organizations, including the Thurgood Marshall College Fund and the National Black Nurses Association, to broaden its reach to underserved communities. Before joining the Alzheimer’s Association, Dr. Hill directed the Office of Special Populations at the National Institute on Aging, focusing on initiatives to diversify the scientific workforce and promote health disparities research related to aging. His work continues to influence efforts toward health equity in Alzheimer’s care and research.
